Alyeska Investment Group, L.P. Merck & Co., Inc. Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $3.06 Million - $3.57 Million	27,057 New	27,057 $3.57 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $87.2 Million - $98.9 Million	-1,044,599 Reduced 99.56%	4,604 $420,000
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $37.1 Million - $40.8 Million	517,525 Added 97.34%	1,049,203 $78.8 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $85.7 Million - $94.8 Million	-1,219,251 Reduced 69.63%	531,678 $41.3 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $5.35 Million - $6.38 Million	-103,574 Reduced 5.59%	1,750,929 $98.5 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $109 Million - $117 Million	1,854,503	1,854,503 $119 Million

3,815

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.